TM

Thangavelu Manimehalai

Active Director Director DIN 10846011
DIN 10846011 First appointment Nov 2024 Primary industry Consumer Products
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Thangavelu Manimehalai

Data last updated:

Thangavelu Manimehalai is a Director at Upstrol Health Care Private Limited (since 2024). The company operates in Consumer Products.

DIN 10846011
Primary Designation Director
Industry Consumer Products
First Appointment 21 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Upstrol Health Care Private Limited U32506TN2024PTC174884
Director21 Nov 20242024Active

Board colleagues of Thangavelu Manimehalai

NameDINCompanyDesignation
Subbiah Sugumaran08191643Upstrol Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Upstrol Health Care Private Limited
Premium access

Shareholding and investment profile for Thangavelu Manimehalai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thangavelu Manimehalai

Thangavelu Manimehalai currently holds 1 directorship: Upstrol Health Care Private Limited (Director, since 21 Nov 2024).

Thangavelu Manimehalai was first appointed on 21 Nov 2024 as Director at Upstrol Health Care Private Limited.

The current boards of Thangavelu Manimehalai's companies include Subbiah Sugumaran (Upstrol Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available